Lysyl oxidase deficiency in Ehlers-Danlos syndrome type V. 1975

N Di Ferrante, and R D Leachman, and P Angelini, and P V Donnelly, and G Francis, and A Almazan

Two maternal cousins affected by the X-linked form of Ehlers-Danlos syndrome have been observed. Both had congenital heart disease, "floppy valve syndrome", hernias, short stature, stretchable skin and moderate joint hypermobility. Both excreted normal amounts of urinary glycosaminoglycans, almost entirely represented by dermatan sulfate, whose degradation appeared to be inadequate. They also excreted large amounts of hydroxylysine glycosides and L-valyl-proline, considered to be products of degradation of collagen and elastin, respectively. Cultured skin fibroblasts of the propositus synthesized excessively soluble collagen and had a low lysyl oxidase activity. These findings suggest that the increased degradation of structural proteins may be secondary to the defective cross-linking processes caused by the enzymic defect. Addition of (+) catechin, a flavonoid, to the propositus's cultured fibroblasts decreased the abnormal solubility of their collagen.

UI MeSH Term Description Entries
D008249 Protein-Lysine 6-Oxidase An enzyme oxidizing peptidyl-lysyl-peptide in the presence of water & molecular oxygen to yield peptidyl-allysyl-peptide plus ammonia & hydrogen peroxide. EC 1.4.3.13. Lysyl Oxidase,Collagen Lysyl Oxidase,6-Oxidase, Protein-Lysine,Lysyl Oxidase, Collagen,Oxidase, Collagen Lysyl,Oxidase, Lysyl,Protein Lysine 6 Oxidase
D008297 Male Males
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D003871 Dermatan Sulfate A naturally occurring glycosaminoglycan found mostly in the skin and in connective tissue. It differs from CHONDROITIN SULFATE A (see CHONDROITIN SULFATES) by containing IDURONIC ACID in place of glucuronic acid, its epimer, at carbon atom 5. (from Merck, 12th ed) Chondroitin Sulfate B,beta-Heparin,Sulfate B, Chondroitin,Sulfate, Dermatan,beta Heparin
D004535 Ehlers-Danlos Syndrome A heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability. Cutis Elastica,Ehlers Danlos Disease,Ehlers-Danlos Disease,Danlos Disease, Ehlers,Disease, Ehlers Danlos,Disease, Ehlers-Danlos,Ehlers Danlos Syndrome,Syndrome, Ehlers-Danlos
D005260 Female Females
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006025 Glycosaminoglycans Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine (see ACETYLGLUCOSAMINE) or N-acetylgalactosamine (see ACETYLGALACTOSAMINE). Glycosaminoglycan,Mucopolysaccharides

Related Publications

N Di Ferrante, and R D Leachman, and P Angelini, and P V Donnelly, and G Francis, and A Almazan
January 2004, Medical journal, Armed Forces India,
N Di Ferrante, and R D Leachman, and P Angelini, and P V Donnelly, and G Francis, and A Almazan
September 1989, The Journal of pediatrics,
N Di Ferrante, and R D Leachman, and P Angelini, and P V Donnelly, and G Francis, and A Almazan
January 2024, Orphanet journal of rare diseases,
N Di Ferrante, and R D Leachman, and P Angelini, and P V Donnelly, and G Francis, and A Almazan
April 1998, Archives of dermatological research,
N Di Ferrante, and R D Leachman, and P Angelini, and P V Donnelly, and G Francis, and A Almazan
January 1997, Clinical and experimental obstetrics & gynecology,
N Di Ferrante, and R D Leachman, and P Angelini, and P V Donnelly, and G Francis, and A Almazan
July 1985, American journal of human genetics,
N Di Ferrante, and R D Leachman, and P Angelini, and P V Donnelly, and G Francis, and A Almazan
March 1988, Journal of neurosurgery,
N Di Ferrante, and R D Leachman, and P Angelini, and P V Donnelly, and G Francis, and A Almazan
April 2001, The Journal of investigative dermatology,
N Di Ferrante, and R D Leachman, and P Angelini, and P V Donnelly, and G Francis, and A Almazan
July 1984, American journal of human genetics,
N Di Ferrante, and R D Leachman, and P Angelini, and P V Donnelly, and G Francis, and A Almazan
September 1976, Archives of ophthalmology (Chicago, Ill. : 1960),
Copied contents to your clipboard!